Posts in Category: hhs

HRSA Audit Results Reveal Manufacturer Overcharges

On January 28, 2020, HRSA posted results
of its 340B Program audit of four pharmaceutical manufacturers in fiscal year 2019.  Three of the four
audited manufacturers were

14 Feb 2020

GAO Issues Report Criticizing HHS’ Oversight of 340B Duplicate Discounts

On January
27, 2020, the U.S. Government Accountability Office (GAO) released a report (the Report) assessing oversight
by the Department of Health and Human Services (HHS) of

31 Jan 2020

MedPAC Finds No Clear Link Between 340B Program and Increased Drug Spend

On January 17, 2020, the Medicare Payment Advisory
Commission (MedPAC) held its first meeting of the year, including a session
discussing a report requested by the House

23 Jan 2020

GAO Issues Report Criticizing HRSA Oversight of Nongovernmental Hospitals

On January
10, 2020, the U.S. Government Accountability Office (GAO) released a report
(the Report) analyzing HRSA’s oversight of 340B eligibility requirements for
nongovernmental hospitals.  The Report concludes

21 Jan 2020

HRSA Awards Prime Vendor Agreement to Apexus

HRSA announced that it has awarded Apexus LLC the prime vendor contract again after a competitive bid process.   Apexus has been the 340B Prime Vendor

13 Jan 2020

CMS Issues Informational Bulletin on State Duplicate Discount Practices

On January
8, 2020, the Centers for Medicare & Medicaid Services (CMS) issued an Informational Bulletin (Bulletin) outlining CMS’s view of
current “best practices” by states to

13 Jan 2020

DC Circuit Rules on 340B Medicare Advantage Discriminatory Reimbursement Case

The federal appeals court for the District of Columbia
Circuit recently ruled in favor of the Humana Medicare Advantage plan in a case
by a 340B covered

9 Jan 2020

Apexus Publishes Tool for Grantee Combined Purchasing and Distribution Requests

Last week, Apexus published a tool which states for the first time HRSA’s policy that all non-FQHC federal grantees are required to register each of

27 Nov 2019

OPA Reevaluates 340B Program Policies

340B Health reports that Capt. Krista Pedley, the Director of OPA, stated last week at the Medicaid Drug Rebate Conference that OPA is reevaluating its

3 Oct 2019

CMS To Survey Hospitals About Acquisition Costs for 340B Drugs

In a Federal Register notice issued yesterday, CMS announced that it intends to survey hospitals on their acquisition costs for covered outpatient drugs purchased under the 340B

1 Oct 2019
Top